This article was originally published on ETFTrends.com.
Global X debuted a new fund on Tuesday that’s among the first ETFs to explicitly track the genomics market with targeted, pure play exposure. The Global X Genomics & Biotechnology ETF (Nasdaq: GNOM) becomes Global X’s 13th fund in its Thematic Growth suite. The new ETF stands to benefit from advances in the field of [...]
Continue Reading Below